Table 2.
Outcomes of Patients With Heart Failure and Atrial Fibrillation and a Cardiovascular Implantable Electronic Device
| Outcome | No Warfarin at Discharge (n = 2049) | Warfarin at Discharge (n = 537) | P Value |
|---|---|---|---|
| Mortality, No. (%) | <0.001 | ||
| 30 days | 112 (5.5) | 29 (5.4) | |
| 1 year | 761 (37.4) | 153 (28.8) | |
| Thromboembolic events, No. (%) | 0.77 | ||
| 30 days | 24 (1.2) | —a | |
| 1 year | 114 (5.6) | 28 (5.3) | |
| New myocardial infarction, No. (%) | 0.87 | ||
| 30 days | 14 (0.7) | —a | |
| 1 year | 60 (2.9) | 15 (2.8) | |
| Bleeding events, No. (%) | 0.86 | ||
| 30 days | 12 (0.6) | —a | |
| 1 year | 88 (4.3) | 22 (4.1) |
a
Cells with ≤10 observations are not shown.